|Articles|February 12, 2021
- Applied Clinical Trials-02-01-2021
- Volume 30
- Issue 1/2
Applied Clinical Trials, January/February 2021 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials January/February 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Impact of COVID-19 on Phase I Clinical Activitiesover 5 years ago
Diversity in Clinical Trials Gains Ground Amidst COVIDover 5 years ago
Biden Pandemic Plan Highlights R&D Supportover 5 years ago
New Alliance Seeks to Bring Increased Accessibility to Trialsover 5 years ago
Improving Drug Development for Rare Patients Post-COVIDover 5 years ago
2021 Promises for Clinical Trialsover 5 years ago
Sharpening the Focus on Patient-Centricity as Pandemic Continuesover 5 years ago
News Notes (January & February)over 5 years ago
EMA’s Cooke Reviews European Cancer ProspectsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy
2
ACT Brief: Organizational Barriers to Programmatic Recruitment, Scaling Selective Safety Data Collection, and Subcutaneous Alzheimer's Treatment
3
Selective Safety Data Collection and the Case for Simpler Trials: Q&A with Rob DiCicco, TransCelerate Biopharma
4
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
5